Literature DB >> 15124253

Development of the BD-QoL: a quality of life measure specific to Behçet's disease.

Gill Gilworth1, M Anne Chamberlain, Bipin Bhakta, Dorian Haskard, Alan Silman, Alan Tennant.   

Abstract

OBJECTIVE: Current outcome measures for patients with Behçet's disease (BD) are impairment-focused and do not necessarily take account of the wider impact of the condition on the individual's lifestyle. Our aim was to develop a disease-specific measure of quality of life (QoL) for BD.
METHODS: The content of the BD-QoL was derived from qualitative interviews with patients using a "needs-based" approach to identify items. A postal survey was used to test the scaling properties, reliability, internal consistency, and validity of the new questionnaire using Rasch analysis. A second postal survey was used to assess test-retest reliability and internal consistency and to provide further evidence of the validity of the questionnaire.
RESULTS: Main themes emerging from the qualitative interviews included relationships, emotions, limitations in day to day activities, and self-image. From these themes 71 statements were chosen as potential items for the BD-QoL. After analysis, 30 items of the BD-QoL emerged free of item bias for age and sex. Fit to the Rasch model was excellent. In the second postal survey test-retest reliability of the 30 item BD-QoL was 0.84.
CONCLUSION: The BD-QoL provides the clinician with a simple, reliable, and valid tool for assessing the influence of interventions for BD and for evaluating models of service delivery. It is well accepted by patients, and has excellent scaling and psychometric properties. The BD-QoL complements information obtained through BD-specific disease activity scales.

Entities:  

Mesh:

Year:  2004        PMID: 15124253

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  18 in total

1.  Arthropathy, quality of life, depression, and anxiety in Behcet's disease: relationship between arthritis and these factors.

Authors:  Ali Gur; Aysegul Jale Sarac; Yahya Kemal Burkan; Kemal Nas; Remzi Cevik
Journal:  Clin Rheumatol       Date:  2006-04-26       Impact factor: 2.980

Review 2.  Current Status, Goals, and Research Agenda for Outcome Measures Development in Behçet Syndrome: Report from OMERACT 2014.

Authors:  Gulen Hatemi; Yesim Ozguler; Haner Direskeneli; Alfred Mahr; Ahmet Gul; Virna Levi; Sibel Z Aydin; Gonca Mumcu; Ozlem Sertel-Berk; Randall M Stevens; Hasan Yazici; Peter A Merkel
Journal:  J Rheumatol       Date:  2015-09-15       Impact factor: 4.666

3.  Behcet's disease.

Authors:  Jagdish R Nair; Robert J Moots
Journal:  Clin Med (Lond)       Date:  2017-02       Impact factor: 2.659

Review 4.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

5.  Behçet syndrome manifestations and activity in the United States versus Turkey -- a cross-sectional cohort comparison.

Authors:  Cailin Sibley; Yusuf Yazici; Koray Tascilar; Nafiz Khan; Yasmin Bata; Hasan Yazici; Raphaela Goldbach-Mansky; Gulen Hatemi
Journal:  J Rheumatol       Date:  2014-06-15       Impact factor: 4.666

6.  Validity and reliability of the Persian version of Behçet's disease quality-of-life (BD-QoL) questionnaire: a cross-cultural adaptation.

Authors:  Mahdi Vojdanian; Seyedeh Tahereh Faezi; Alan Tennant; Ann W Morgan; Pedram Paragomi; Mostafa Qorbani; Maryam Mattaji; Fereydoun Davatchi
Journal:  Rheumatol Int       Date:  2014-09-13       Impact factor: 2.631

7.  Validity and reliability of the Dutch adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) Questionnaire.

Authors:  Freke Wink; Suzanne Arends; Stephen P McKenna; Pieternella M Houtman; Elisabeth Brouwer; Anneke Spoorenberg
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

Review 8.  Measuring patient-reported outcomes: moving beyond misplaced common sense to hard science.

Authors:  Stephen P McKenna
Journal:  BMC Med       Date:  2011-07-14       Impact factor: 8.775

9.  Cross-cultural adaptation and validation of Behçet's disease quality of life questionnaire.

Authors:  Zahi Touma; Lilian Ghandour; Abla Sibai; Houry Puzantian; Ayad Hamdan; Omar Hamdan; Jeanine Menassa; Imad Uthman; Thurayya Arayssi
Journal:  BMC Med Res Methodol       Date:  2011-04-20       Impact factor: 4.615

10.  The Behcet's Disease Quality of Life: reliability and validity of the Korean version.

Authors:  Sang Won Yi; Ji-Hae Kim; Ki-Young Lim; Dongsik Bang; Sungnack Lee; Eun-So Lee
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.